Royal Philips has reported second-quarter profit margins that exceeded market expectations, driven largely by refunds on US tariffs previously imposed on its imports.
The Dutch healthcare technology company also raised its full-year 2026 outlook, explicitly incorporating the financial benefits from these repaid levies into its forward guidance.
The results underscore the immediate financial relief available to multinationals navigating the evolving US trade landscape.
Philips joins Pandora as one of the first major companies to confirm receipt of funds under the new US tariff refund program, a move that signals a tangible shift in Washington’s trade policy.
The Trump administration has begun disbursing refunds for tariffs on imported goods, marking a departure from earlier protectionist measures and offering a direct boost to corporate bottom lines.
For investors, the upgraded outlook suggests that the tariff refund mechanism is not merely a one-off accounting adjustment but a structural benefit that can be factored into longer-term earnings models.